| [1] |
SU Ya, ZHANG Dongwei, YU Minghui, WANG Chunhua, WU Yueyue.
Observation on the clinical efficacy of compound kushen injection combined with targeted and immune therapy in the treatment of advanced hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2026, 54(3): 324-328.
|
| [2] |
WANG Zhe, QIU Lin, MA Ben.
Research on the effect of tomato derived nanovesicles on oral squamous cell carcinoma
[J]. Tianjin Medical Journal, 2026, 54(2): 145-150.
|
| [3] |
ZHANG Xinglong, HE Hongmei, ZHANG Jing, SHI Ya’nan, REN Lanchun, QIN Xiaohui, SUN Jianghua.
The clinical efficacy of artificial pleural effusion combined with radiofrequency ablation in patients with phrenic top liver cancer
[J]. Tianjin Medical Journal, 2025, 53(8): 856-859.
|
| [4] |
YU Songsong, YIN Jingzhao, WU Tianyu, LI Hao.
Gli gene and protein expression in hepatocellular carcinoma and the relationship with prognosis
[J]. Tianjin Medical Journal, 2025, 53(2): 124-128.
|
| [5] |
XIE Yindong, ZHOU Ying, LI Yanping, NIU Yajing, SU Qichao.
The effect of dexmedetomidine on the biological behavior of gallbladder cancer cells by regulating the CCL2-CCR2 pathway
[J]. Tianjin Medical Journal, 2025, 53(12): 1233-1240.
|
| [6] |
LIANG Damin, YANG Zhengjiu, ZHANG Ziping, QIAN Jing, MAO Chaokun.
Study on the effect and mechanism of kaempferol in reversing drug-resistant Bel-7402/5-Fu cells
[J]. Tianjin Medical Journal, 2024, 52(9): 900-906.
|
| [7] |
WANG Yuanzhen, WEI Hongyan, CHANG Lixian, ZHANG Yingyuan, LIU Chunyun, LIU Li.
Establishment and validation of a risk prediction model for primary liver cancer complicated with pulmonary infection before intervention
[J]. Tianjin Medical Journal, 2024, 52(9): 940-945.
|
| [8] |
WU Jing, FAN Zhijuan, LIU Shuye.
Changes and clinical significance of plasma free amino acid levels in the development of chronic hepatitis B to hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 738-742.
|
| [9] |
LIU Xiaoyan, BU Rui, LU Jianfei, DING Yu, ZHANG Xing.
Value of Sonazoid contrast-enhanced ultrasound for preoperatively evaluating pathological grade of hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(6): 658-662.
|
| [10] |
NING Yinkuan, LIU Linzhi, CHEN Xianping.
Experimental study on the mineralization of rabbit bone marrow mesenchymal stem cells after transfection with BMP2 recombinant lentivirus
[J]. Tianjin Medical Journal, 2023, 51(5): 454-459.
|
| [11] |
WU Qiong, LI Jinyuan, HUANG Wentao, AN Na.
Effects of acacetin on proliferation, apoptosis and migration of hepatocellular carcinoma HepG2 cells and its mechanism
[J]. Tianjin Medical Journal, 2023, 51(3): 235-239.
|
| [12] |
TANG Haoyan, PAN Zhenglong, LIU Xiaofang.
Association between single nucleotide polymorphism of TP53 gene and prognosis of primary hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2023, 51(11): 1249-1254.
|
| [13] |
REN Zhixing, YANG Guanghua.
Study on the mechanism of CDCA8 promoting the occurrence of prostate cancer by regulating proliferation
[J]. Tianjin Medical Journal, 2022, 50(8): 796-801.
|
| [14] |
LYU Kangning, , WANG Lei, QIN Song, WANG Li△.
Research progress of the protective effect and mechanism of C-phycocyanin on liver injury
[J]. Tianjin Medical Journal, 2022, 50(6): 668-672.
|
| [15] |
TAN Yuying, ZHANG Weiqi, XIE Yan, LI Jiang, LI Junjie, JIANG Wentao△.
The risk factor analysis and predictive model construction of microvascular invasion in hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2022, 50(5): 523-527.
|